M2M

Alicia Timme-Laragy, PhD
  • IALS | M2M 

Alicia Timme-Laragy Offers Expertise to National Academies Committee on Role of Seafood in Child Development

Alicia Timme-Laragy, professor of environmental health sciences, Models to Medicine Center, whose research focuses on developmental toxicology and environmental pollutants, recently served as an expert consultant for the National Academies Committee for their study, “The Role of Seafood in Child Growth and Development,” for the U.S. Food and Drug Administration (FDA).

Learn More
DNA-Encoded Library Screening
  • M2M 

DNA-Encoded Library Screening

The Models to Medicine Center is announcing funding for up to five pilot projects focused on DNA-encoded library screening. The successful applicants will embark on projects aimed at discovering novel chemical compounds with therapeutic potential by leveraging DNA-encoded libraries at WuXi DELopen libraries. 

Learn More
2023 Best Scientists Researchcom
  • IALS | CBD | CPHM | M2M 

Four UMass Amherst Researchers Named in 2023 “Best Scientists in the World” Ranking By Research.com

Four UMass Amherst faculty scholars representing a range of disciplines in the natural and health sciences have been recognized nationally and globally in Research.com’s 2023 list of top scientists and also earned high rankings in their specific fields of research. All four of these researchers are affiliated with an IALS Research Center, with all three Centers being represented on this list.

Learn More
Krishna Live Cell Protein Labeling
  • IALS | CBD | CPHM | M2M 

IALS Announces Inaugural Graduate Student Fellows for 2024

IALS is excited to announce the inaugural one-year translational Graduate Student Fellows for 2024! 

We define translational research as work that aims to inform or to develop product candidates, technologies, and services that deliver benefits to human health and well-being.

Learn More
Anna Green, PhD
  • M2M | IALS Interview Series 

IALS Interview with Anna Green

Anna Green is an Assistant Professor in the Manning College of Information & Computer Sciences, and a member of the Models to Medicine Center in IALS.

Learn More
Cana Park
  • CBD | M2M | IALS Interview Series 

IALS Interview with Cana Park

Cana Park is an assistant professor in the Department of Biology, and a member of the Models to Medicine Center and the Center for Bioactive Delivery in IALS

Learn More
David A. Sela, PhD
  • CBD | M2M | IALS Interview Series 

IALS Interview with David Sela

Professor Sela is an Associate Professor in the Department of Food Science, and a member of the Center for Bioactive Delivery and the Models to Medicine Center in IALS.

Learn More
Daniel Hebert - Mass Spectrometry
  • IALS | M2M 

M2M’s Daniel Hebert Uses Mass Spectrometry to Unlock Cellular Code on Protein Folding, Opening Therapeutic Avenues for Many Diseases

While we often think of diseases as caused by foreign bodies—bacteria or viruses—there are hundreds of diseases affecting humans that result from errors in cellular production of its proteins. A team of UMass researchers recently leveraged the power of cutting-edge technology to unlock the carbohydrate-based code that governs how certain classes of proteins form themselves into the complex shapes necessary to keep us healthy.

Learn More
Craig Martin and Sarah Perry
  • CBD | M2M 

Martin and Perry to Help Launch the Future of RNA Research and Biomedicine

Craig Martin, professor of chemistry, Models to Medicine Center, and Sarah Perry, associate professor of chemical engineering, Center for Bioactive Delivery, recently received support from the National Institutes of Health (NIH) to develop an innovative approach toward efficiently, reliably and cost effectively synthesizing novel strands of specialty “long RNA.” Future genetic research into everything from basic cell biology to advanced therapeutics depends in part on having just the sort of complex, modified RNA that Martin and Perry will be working to make widely available.

Learn More
Jeanne Hardy and Jasna Fejzo
  • IALS | M2M | Core Facilities 

NMR Core Facility Receives $4.4 Million from MLSC for Advanced Atomic Resolution Instrument

IALS has received more than $4.4 million from the Massachusetts Life Sciences Center (MLSC) to acquire an 800 MHz Nuclear Magnetic Resonance (NMR) spectrometer. This high-field atomic resolution instrument will aid researchers working to develop the next generation of drugs to treat high unmet-need diseases, including various types of cancer and Alzheimer’s disease.

Learn More
Sarah Perry, PhD
  • CBD | M2M 

Sarah Perry to Receive American Chemical Society Young Investigator Award

Sarah Perry, associate professor in the Department of Chemical Engineering, Center for Bioactive Delivery, Models to Medicine Center, has been chosen as one of two national recipients of the 2024 American Chemical Society (ACS) Macro Letters/Biomacromolecules/Macromolecules Young Investigator Award for her contributions to the field of polyelectrolyte self-assembly and the incorporation of proteins into these assemblies.

Learn More